These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26565779)

  • 1. Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents.
    Farah SI; Abdelrahman AA; North EJ; Chauhan H
    Assay Drug Dev Technol; 2016; 14(1):29-38. PubMed ID: 26565779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspectives on natural products in TB drug research.
    Pauli GF; Case RJ; Inui T; Wang Y; Cho S; Fischer NH; Franzblau SG
    Life Sci; 2005 Dec; 78(5):485-94. PubMed ID: 16243360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitubercular Marine Natural Products.
    Wang L; Wang J; Liu J; Liu Y
    Curr Med Chem; 2018; 25(20):2304-2328. PubMed ID: 28088903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel and revisited approaches in antituberculosis drug discovery.
    Herrmann J; Rybniker J; Müller R
    Curr Opin Biotechnol; 2017 Dec; 48():94-101. PubMed ID: 28427007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery.
    Cazzaniga G; Mori M; Chiarelli LR; Gelain A; Meneghetti F; Villa S
    Eur J Med Chem; 2021 Nov; 224():113732. PubMed ID: 34399099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in antitubercular natural products.
    García A; Bocanegra-García V; Palma-Nicolás JP; Rivera G
    Eur J Med Chem; 2012 Mar; 49():1-23. PubMed ID: 22280816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target discovery focused approaches to overcome bottlenecks in the exploitation of antimycobacterial natural products.
    Baptista R; Bhowmick S; Nash RJ; Baillie L; Mur LA
    Future Med Chem; 2018 Apr; 10(7):811-822. PubMed ID: 29569936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model to predict anti-tuberculosis activity: value proposition for marine microorganisms.
    Liu M; Grkovic T; Zhang L; Liu X; Quinn RJ
    J Antibiot (Tokyo); 2016 Aug; 69(8):594-9. PubMed ID: 27406906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural antimicrobial peptides against Mycobacterium tuberculosis.
    Abedinzadeh M; Gaeini M; Sardari S
    J Antimicrob Chemother; 2015 May; 70(5):1285-9. PubMed ID: 25681127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on tuberculosis pathogenesis and discovery of anti- tubercular drugs.
    Ntie-Kang F; Yong JN; Owono Owono LC; Sippl W; Megnassan E
    Curr Med Chem; 2014; 21(30):3466-77. PubMed ID: 25005178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recently disclosed chemical entities as potential candidates for management of tuberculosis.
    Stec J; Abourashed EA
    Pharm Pat Anal; 2015; 4(4):317-47. PubMed ID: 26174569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in natural product-based drug discovery for tuberculosis.
    Dong M; Pfeiffer B; Altmann KH
    Drug Discov Today; 2017 Mar; 22(3):585-591. PubMed ID: 27890820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
    Bhat ZS; Rather MA; Maqbool M; Ahmad Z
    Biomed Pharmacother; 2018 Jul; 103():1733-1747. PubMed ID: 29864964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural products as leads for tuberculosis drug development.
    Salomon CE; Schmidt LE
    Curr Top Med Chem; 2012; 12(7):735-65. PubMed ID: 22283816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the tuberculosis drug development pipeline.
    Evangelopoulos D; McHugh TD
    Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug development against tuberculosis: Impact of alkaloids.
    Mishra SK; Tripathi G; Kishore N; Singh RK; Singh A; Tiwari VK
    Eur J Med Chem; 2017 Sep; 137():504-544. PubMed ID: 28628823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting natural product value, an exploration of anti-TB drug space.
    Dashti Y; Grkovic T; Quinn RJ
    Nat Prod Rep; 2014 Aug; 31(8):990-8. PubMed ID: 24881816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives in drug discovery against tuberculosis from natural products.
    Nguta JM; Appiah-Opong R; Nyarko AK; Yeboah-Manu D; Addo PG
    Int J Mycobacteriol; 2015 Sep; 4(3):165-83. PubMed ID: 27649863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.